Endevica Bio
PrivateLast Round
Series B
Jan 19, 2023
Total Funding Raised
$16.27M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Endevica Bio is a biotechnology company that develops first-in-class peptide drug candidates for the treatment of cachexia caused by cancer and other chronic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endevica Bio Comparables
Compare Endevica Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kalohexis | 85% | |
| NGM Biopharmaceuticals | 81% | |
| Actimed Therapeutics | 79% |
Endevica Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 19, 2023 | ||||
| Grant | Jun 1, 2017 | ||||
| Seed | Jun 1, 2016 |
Key People
Founding team and executive leadership
Endevica Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centennial Investors | Angel, Seed, Series B |
| National Cancer Institute | Grant |
| Missouri Technology Corporation | Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 31% MoM.
- May 28, 2025
Developing a peptide therapeutic drug to combat cachexia.
Endevica Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Endevica Bio's valuation, stock price, and market status.
Is Endevica Bio a public or private company?
Endevica Bio is a private company.
What is the current stock price of Endevica Bio?
Endevica Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Endevica Bio worth (valuation)?
Valuation information for Endevica Bio is not publicly available.
Can I buy Endevica Bio stock?
Endevica Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Endevica Bio's last funding round?
Endevica Bio's most recent funding round was Series B on January 19, 2023.
Who are the main investors in Endevica Bio?
Key investors in Endevica Bio include Centennial Investors, Missouri Technology Corporation.
Will Endevica Bio IPO soon?
No public IPO plans have been announced for Endevica Bio.
How can I track Endevica Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Endevica Bio's secondary market activity and sign up for updates.